The antidote : (Record no. 237)

000 -LEADER
fixed length control field 03022cam a2200445 i 4500
001 - CONTROL NUMBER
control field 17904169
003 - CONTROL NUMBER IDENTIFIER
control field KPN
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20211006155806.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 130930s2014 nyua b 001 0 eng
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
LC control number 2013039646
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781451655667 (hardback)
International Standard Book Number 9781451655674 (trade paperback)
Canceled/invalid ISBN 9781451655698 (ebook)
040 ## - CATALOGING SOURCE
Original cataloging agency DNLM/DLC
Transcribing agency DLC
Description conventions rda
Modifying agency DLC
042 ## - AUTHENTICATION CODE
Authentication code pcc
050 00 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RA401.A3
Item number W37 2014
060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QV 736 AA1
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 338.4/76151
Edition number 23
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Werth, Barry,
Relator term author.
245 14 - TITLE STATEMENT
Title The antidote :
Remainder of title inside the world of new pharma /
Statement of responsibility, etc. Barry Werth.
250 ## - EDITION STATEMENT
Edition statement First Simon & Schuster hardcover edition.
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. New York
Name of publisher, distributor, etc. Simon & Schuster
Date of publication, distribution, etc. 2014
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture New York :
Name of producer, publisher, distributor, manufacturer Simon & Schuster,
Date of production, publication, distribution, manufacture, or copyright notice 2014.
300 ## - PHYSICAL DESCRIPTION
Extent x, 435 pages :
Other physical details illustration ;
Dimensions 25 cm
336 ## - CONTENT TYPE
Content type term text
Source rdacontent
337 ## - MEDIA TYPE
Media type term unmediated
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term volume
Source rdacarrier
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Includes bibliographic references (pages 401-416) and index.
520 ## - SUMMARY, ETC.
Summary, etc. "This is the Moneyball of the pharma world, the story of one drug company's quest to transform the pharmaceutical industry and a deeply revealing look into a world where breakneck capitalism meets life-saving medicine.The $325 billion-a-year pharmaceutical business is America's most challenging and one of its most profitable. It is tougher in just about every way than any other enterprise: from the towering biological risks inherent in its mission to treat disease; to the thirty-to-one failure rate in bringing out a successful medicine after a candidate clears all the hurdles to get to human testing; to the billion-dollar-plus cost of ramping up a successful product; to operating in the worlds most highly regulated industry with the possible exception of nuclear power. The Antidote tells the story of Vertex, a maverick drug company led by the charismatic Joshua Boger and a small group of entrepreneurial young scientists who broke off from Merck when it was the world's best drug maker, indeed the most admired business in America because they thought they could make drugs better. Building upon his widely praised The Billion-Dollar Molecule, Barry Werth captures the full scope of Vertex's twenty-five-year drive to liver breakthrough medicines and transform the drug industry. The Antidote draws upon unprecedented inside reporting spanning more than two decades to provide a groundbreaking close-up of Vertex's inner workings and the ferocious but indispensable world it inhabits"--Provided by publisher.
546 ## - LANGUAGE NOTE
Language note In English
610 22 - SUBJECT ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element Vertex Pharmaceuticals Incorporated.
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Industry
Geographic subdivision United States.
Topical term or geographic name entry element Drug Industry
General subdivision history
Geographic subdivision United States.
Topical term or geographic name entry element History, 20th Century
Geographic subdivision United States.
Topical term or geographic name entry element History, 21st Century
Geographic subdivision United States.
Topical term or geographic name entry element Technology, Pharmaceutical
Geographic subdivision United States.
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN)
a 7
b cbc
c orignew
d 1
e ecip
f 20
g y-gencatlg
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
Koha item type Book
Suppress in OPAC No
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Collection code Home library Current library Shelving location Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
          Non-fiction Perpustakaan Kementerian Perpaduan Malaysia Perpustakaan Kementerian Perpaduan Malaysia Non- Fiction Rack - Social sciences 06/10/2021   338.4 WER 2014 KPN21100065 06/10/2021 06/10/2021 Book